Thomas Cancro - 28 Feb 2022 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: N/A
Reported as of: 28 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2022, 16:49:18 UTC
Prior SEC filing: 06 Jul 2021
Next SEC filing: 14 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian W. Adams, by Power of Attorney

Key filing fact

Thomas Cancro filed Form 4 for Tabula Rasa HealthCare, Inc. on 04 Mar 2022.

Key facts

This page summarizes Thomas Cancro's Form 4 filing for Tabula Rasa HealthCare, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2022, 16:49.

Change

Previous filing in this sequence was filed on 06 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRHC transaction

Common Stock

Award

Transaction value: $0
Shares: +200,000
Change %
Price: $0.000000
Shares after: 200,000
Date: 28 Feb 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F2

The restricted stock units vest in four equal installments on February 24, 2022, February 24, 2023, February 24, 2024, and February 24, 2025, subject to the reporting person's continued employment through each such vesting date.